ConductScience.org, home

Trial · NCT05066230

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Primary Study (Through Week 48)STARTEDKSI-301 - Treatment Group A128
Primary Study (Through Week 48)STARTEDTreatment Group B125
Primary Study (Through Week 48)COMPLETEDKSI-301 - Treatment Group A120
Primary Study (Through Week 48)COMPLETEDTreatment Group B115
Primary Study (Through Week 48)NOT COMPLETEDKSI-301 - Treatment Group A8
Primary Study (Through Week 48)NOT COMPLETEDTreatment Group B10
After Week 48STARTEDKSI-301 - Treatment Group A120
After Week 48STARTEDTreatment Group B115
After Week 48COMPLETEDKSI-301 - Treatment Group A0
After Week 48COMPLETEDTreatment Group B0
After Week 48NOT COMPLETEDKSI-301 - Treatment Group A120
After Week 48NOT COMPLETEDTreatment Group B115

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05066230/flow